Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRAF family member-associated NF-kappa-B activator (TANK) is a cytoplasmic multifunctional adaptor protein that regulates immune signaling, particularly in pathways leading to the activation or inhibition of NF-kappa-B, a key transcription factor in inflammation, immunity, and cell survival. TANK binds to several TRAF family proteins (TRAF1, TRAF2, TRAF3), often sequestering them and thus inhibiting their downstream signal transduction. It also interacts with TANK-binding kinase 1 (TBK1) and IKBKE, participating in noncanonical NF-kappa-B and antiviral innate immune responses. TANK's activity is context-dependent—it can act both as an inhibitor and coactivator in TRAF-mediated signaling, modulating the activity of TBK1 and the assembly of kinase complexes upstream of NF-kappa-B. Mutations or dysregulation of TANK have been associated with susceptibility to neurological and infectious diseases, and potentially with dysregulated inflammatory states[1][2][3][4].
Not applicable for current drug targeting; compound approaches would theoretically modulate immune signaling or NF-kappa-B activation via TANK[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRAF family member-associated NF-kappa-B activator (TANK).